Atrial Fibrillation (AFib) Support Group
Atrial fibrillation (AF or afib) is an abnormal heart rhythm (cardiac arrhythmia) which involves the two small, upper heart chambers (the atria). Heart beats in a normal heart begin after electricity generated in the atria by the sinoatrial node spread through the heart and cause contraction of the heart muscle and pumping of blood.
I could be wrong but I think the problem with warfarin is that people eliminate vitamin k. Towards the end of her life I started giving her a daily vitamin k supplement and they adjusted her warfarin accordingly. Vitamin k helps stop calcium from building up in the arteries. When she first started on warfarin they had her avoiding all greens. The trick is to eat the same amount daily.
I am assuming the newer blood thinners don't cause this problem because you do not need to avoid vitamin k with them.
Medical News Today had this article on their front page, too:
http://www.medicalnewstoday.com/articles/310148.php
Yoga, meditation may reduce dementia risk
So, it looks like if you do yoga AND take your anticoagulant youre working a balanced game.
Carpe diem,
atp
I had brain scan 1 1/2 years ago when I fell and hit my head on sidewalk. I was okay. He sewed up the cut. and kept me all night.
Since our initial discovery, we had tried to understand the association. So far we have found five clinical risk factors in atrial fibrillation patients that raise the risk of dementia:
1. Type, duration, and efficacy of anticoagulation treatment. Most atrial fibrillation patients are treated with anticoagulation to lower their risk of stroke. Worldwide, the most common drug used is warfarin (coumadin). Warfarin levels can be erratic in some people, often exposing them to periods of both under- and over-anticoagulation. The most exposure to periods of under- or over-anticoagulation raises risk of dementia significantly. These findings suggest that one of the reasons people with atrial fibrillation develop dementia is that they are exposed to small clots or bleeds within the brain, or both. This dementia risk is increased in atrial fibrillation patients who need to take aspirin or plavix because they have had a prior heart attack, stent, or bypass surgery. In this latter scenario, the added anticoagulant effects of aspirin likely increase risk of microbleeds.
2. Sleep apnea. Patients with untreated sleep apnea have a 50 percent chance of developing atrial fibrillation. Sleep apnea leads to acceleration and worsening of atrial fibrillation. Untreated sleep apnea also makes it much more difficult to treat atrial fibrillation. Sleep apnea also is associated with cognitive decline and dementia.
3. Heart rate. The heart often compensates for a slight loss in efficacy from atrial fibrillation by elevating the heart rate. We treat elevated heart rates to minimize risk of heart failure with atrial fibrillation. However, when the heart rate falls below 70 beats per minute (a normal level in people without atrial fibrillation), organ perfusion can be impacted. We have found an inverse association between heart rate and dementia risk, i.e., the lower the average heart rate over 24 hours, the greater the risk. The risk of dementia goes up when the average 24-hour heart rate is below 70 beats per minute in people who are in atrial fibrillation all the time. In these people, we are lowering the levels of medications used to slow the heart rate, and in some people who continue to have slow heart rates we are placing pacemakers to raise the heart rate.
4. Genetic factors. We have found genetic mutations associated with early atrial fibrillation and with stroke and thrombosis that predict early onset dementia. In this case, people who have first-degree relatives with early atrial fibrillation and dementia may be at increased risk. In those people, we are particularly careful in regard to the risk factors noted above to minimize any additional risk.
5. Inactivity. Inactivity and lack of exercise is a significant risk factor for atrial fibrillation and cognitive decline. We believe that if we start increasing activity to promote weight loss early after atrial fibrillation develops, the negative effects of the arrhythmia can be significantly reduced. Activity and exercise also lead to healthier vessels of organs such as the brain, which improves its perfusion and function over a lifetime.
http://www.medscape.com/viewarticle/835063
Todd
"The Apixaban Versus Acetylsalicylic acid (ASA) to Prevent Strokes (AVERROES) trial18 was a randomized double-blind trial designed to compare apixaban 5 mg twice-daily vs. aspirin (81-324 mg/day) for stroke prevention in patients with AF and at least one additional risk factor for stroke, but considered "unsuitable" to treatment with warfarin. In a population with a mean age of 70 years, the study reported a comparable incidence of ICH for aspirin and apixaban. 11 intracranial bleeds were reported with apixaban and 13 with aspirin (0.4% per annum for both, OR for apixaban vs. aspirin: 0.85, 95% CI 0.38-1.90). - "
"Summary Intracranial hemorrhage (ICH) is a growing cause of death and disability worldwide, because of the increasing number of elderly people and the increasing use of oral anticoagulants (OACs). Even a perfectly conducted VKA treatment, with international normalized ratio (INR) between 2 and 3 in AF patients, doubles the risk of ICH. ICH is significantly reduced in patients receiving new oral anticoagulants (NOACs) compared to warfarin; all four pivotal trials reported a risk reduction by roughly a half, which represents a substantial benefit of treatment with NOACs. The annual incidence of ICH in populations not treated with any anticoagulant is closely related to patients' age, and when adjusted by the age of the cohort under study it seems not too far from the annual incidence reported in patients taking NOACs. It has been hypothesized that, by selectively targeting thrombin and not interfering with the formation of TF-VIIa complexes, NOACs preserve hemostatic mechanisms in the brain, while warfarin does not. The lower rate of ICH reported for these drugs compared with warfarin can also be explained by the peculiar interaction of NOACs with the transport mechanism of P-glycoprotein. "
Clearly, NOACs are the safest and most effective AFIB treatments to prevent stroke, while not causing ICH (intercranial hemorrhage). Pradaxa is now reversible also!
Journal of the American Medical Association 201010, 11 Scottish study found that aspirin did not help prevent heart attacks or strokes in healthy, asymptomatic individuals with a high risk of heart disease